Alzheimer's disease and endothelial dysfunction

Neurological Sciences

Volumn 31, Issue 1, 2010, Pages 1-8

  Bomboi, Giuseppe ^a   Castello, Lorenzo ^a   Cosentino, Francesco ^a   Giubilei, Franco ^a   Orzi, Francesco ^a,c   Volpe, Massimo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; Dementia; Endothelial dysfunction; Hypertension; Neuropsychological evaluation; Vascular dysregulation

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ARGININE DERIVATIVE; ASCORBIC ACID; CALCIUM ANTAGONIST; CANDESARTAN; CELECOXIB; ENALAPRIL; GLYCOPROTEIN; HYDROCHLOROTHIAZIDE; INDOMETACIN; N(G) METHYLARGININE; NITRENDIPINE; NITRIC OXIDE SYNTHASE; PERINDOPRIL; PLACEBO; PROSTAGLANDIN SYNTHASE; TAU PROTEIN;

ALZHEIMER DISEASE; CELL INTERACTION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME RELEASE; GLIA CELL; HEART MUSCLE CELL; HUMAN; HYPERTENSION; MULTIINFARCT DEMENTIA; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; PSYCHOLOGIC ASSESSMENT; REVIEW; RISK FACTOR; SENILE PLAQUE; SMOOTH MUSCLE FIBER; SYSTEMIC DISEASE; VASCULAR DISEASE;

ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; ENDOTHELIUM, VASCULAR; HUMANS; INTRACRANIAL HYPERTENSION;

EID: 76449116679     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0151-6     Document Type: Review

References (72)

1. AF Jorm AE Korten AS Henderson 1987 The prevalence of dementia: a quantitative integration of the literature Acta Psychiatr Scand 76 465 479
2. AI Bush 2003 Copper, zinc, and the metallobiology of Alzheimer disease Alz Dis Assoc Dis 17 147 150
3. G Bomboi F Marchione M Sepe-Monti A De Carolis V Bianchi E Medda A Pino B Bocca G Forte C D'Ippolito F Giubilei 2005 Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease Ann Ist Super Sanita 41 205 212
4. RG Riekse JB Leverenz W McCormick JD Bowen L Teri D Nochlin K Simpson C Eugenio EB Larson D Tsuang 2004 Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study J Am Geriatr Soc 52 1442 1448
5. H Petrovitch GW Ross SC Steinhorn RD Abbott W Markesbery D Davis J Nelson J Hardman K Masaki MR Vogt L Launer LR White 2005 AD lesions and infarcts in demented and non-demented Japanese-American men Ann Neurol 57 98 103
6. K Rockwood H Davis C MacKnight R Vandorpe S Gauthier A Guzman P Montgomery S Black DB Hogan A Kertesz R Bouchard H Feldman 2003 The consortium to investigate vascular impairment of cognition: methods and first findings Can J Neurol Sci 30 237 243
7. M van Oijen FJ de Jong JC Witteman A Hofman PJ Koudstaal MM Breteler 2007 Atherosclerosis and risk for dementia Ann Neurol 61 403 410
8. A Hofman A Ott MM Breteler ML Bots AJ Slooter F van Harskamp CN van Duijn C Van Broeckhoven DE Grobbee 1997 Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study Lancet 349 151 154 (Pubitemid 27039193)
9. A Ott MM Breteler F van Harskamp T Stijnen A Hofman 1988 Incidence and risk of dementia. The Rotterdam Study Am J Epidemiol 147 574 580
10. R Monastero K Palmer C Qiu B Winblad L Fratiglioni 2007 Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the Kungsholmen Project Am J Geriatr Psychiatry 15 60 69
11. WL Xu CX Qiu A Wahlin B Winblad L Fratiglioni 2004 Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study Neurology 63 1181 1186 (Pubitemid 39350014)
12. C Qiu E von Strauss J Fastbom, et al. 2003 Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study Arch Neurol 60 223 228 10.1001/archneur.60.2.223 12580707 (Pubitemid 36193966)
13. LJ Launer K Andersen ME Dewey, et al. 1999 Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia Neurology 52 78 84
14. LJ Launer K Masaki H Petrovitch, et al. 1995 The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study JAMA 274 1846 1851 10.1001/jama.274.23.1846 (Pubitemid 26001260)
15. C Iadecola 2004 Neurovascular regulation in the normal brain and in Alzheimer's disease Nat Rev Neurosci 5 347 360 10.1038/nrn1387
16. JC de la Torre 2004 Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics Lancet Neurol 3 184 190 10.1016/S1474-4422(04)00683-0 (Pubitemid 38232669)
17. RN Kalaria 2000 The role of cerebral ischemia in Alzheimer's disease Neurobiol Aging 21 321 330 10.1016/S0197-4580(00)00125-1 (Pubitemid 30387091)
18. BC Lee M Mintun RL Buckner JC Morris 2003 Imaging of Alzheimer's disease J Neuroimag 13 199 214
19. SI Rapoport 1999 Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation Ann N Y Acad Sci 893 138 153 10.1111/j.1749-6632.1999.tb07823.x
20. S Pakrasi JT O'Brien 2005 Emission tomography in dementia Nucl Med Commun 26 189 196 10.1097/00006231-200503000-00003 15722899 (Pubitemid 40411042)
21. KJ Bar MK Boettger N Seidler, et al. 2007 Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy Stroke 38 3186 3192 10.1161/STROKEAHA.107.492033 17962592 (Pubitemid 350175735)
22. H Girouard C Iadecola 2006 Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease J Appl Physiol
23. FM Faraci DD Heistad 1998 Regulation of the cerebral circulation: role of endothelium and potassium channels Physiol Rev 78 53 97
24. Heistad DD, Kontos HA (1983) Cerebral circulation. In: Handbook of Physiology. The cardiovascular system. Circulation and organ blood flow. American Physiol Soc, Bethesda, MD, sect 2, vol III, pt 1, chap 5, pp 137-82
25. JR Jennings MF Muldoon C Ryan, et al. 2005 Reduced cerebral blood flow response and compensation among patients with untreated hypertension Neurology 64 1358 1365
26. M Sausbier R Schubert V Voigt, et al. 2000 Mechanisms of NO/cGMP-dependent vasorelaxation Circ Res 87 825 830
27. K Kazama G Wang K Frys, et al. 2003 Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex Am J Physiol Heart Circ Physiol 285 1890 1899
28. P Vallance N Chan 2001 Endothelial function and nitric oxide: clinical relevance Heart 85 342 350 10.1136/heart.85.3.342
29. PA Marsden HH Heng SW Scherer, et al. 1993 Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene J Biol Chem 268 17478 17488
30. MW Radomski RM Palmer S Moncada 1987 The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide Br J Pharmacol 92 639 646
31. Lüscher TF, Vanhoutte PM (1990) The Endothelium: Modulator of Cardiovascular Function. CRC Press, Boca Raton, Fla, pp 1-215
32. R De Caterina P Libby HB Peng, et al. 1995 Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines J Clin Invest 96 60 68 10.1172/JCI118074 7542286
33. TW Gauthier R Scalia T Murohara, et al. 1995 Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia Arterioscler Thromb Vasc Biol 15 1652 1659
34. JY Jeremy D Rowe AM Emsley AC Newby 1999 Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res 43 580 594
35. RK Dubey EK Jackson TF Luscher 1995 Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin 1 receptors J Clin Invest 96 141 149
36. JA Panza AA Quyyumi JE Brush Jr SE Epstein 1990 Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension N Engl J Med 323 22 27
37. C Cardillo CM Kilcoyne RO Cannon 3rd JA Panza 1998 Impairment of the nitric oxide-mediated vasodilator response to mental stress in hypertensive but not in hypercholesterolemic patients J Am Coll Cardiol 32 1207 1213 10.1016/S0735-1097(98)00391-X (Pubitemid 28522375)
38. JA Panza PR Casino CM Kilcoyne AA Quyyumi 1994 Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level J Am Coll Cardiol 23 1610 1616
39. JA Panza CE García CM Kilcoyne, et al. 1995 Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway Circulation 91 1732 1738
40. MA Creager MA Roddy 1994 Effect of captopril and enalapril on endothelial function in hypertensive patients Hypertension 24 499 505
41. SM Wallace A Yasmin CM McEniery, et al. 2007 Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction Hypertension 50 228 233 10.1161/HYPERTENSIONAHA.107.089391 (Pubitemid 46986045)
42. A Scuteri AM Brancati W Gianni, et al. 2005 Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: a pilot study J Hypertens 23 1211 1216 10.1097/01.hjh.0000170384.38708.b7
43. A Scuteri M Tesauro S Appolloni F Preziosi AM Brancati M Volpe 2007 Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual J Hypertens 25 1035 1040 10.1097/HJH.0b013e3280895b55 (Pubitemid 46573123)
44. S Taddei A Virdis P Mattei A Salvetti 1993 Vasodilation to acetylcholine in primary and secondary forms of human hypertension Hypertension 21 929 933
45. Y Higashi S Sasaki K Nakagawa, et al. 2002 Endothelial function and oxidative stress in renovascular hypertension N Engl J Med 346 1954 1962 10.1056/NEJMoa013591 (Pubitemid 34651355)
46. S Taddei A Virdis P Mattei, et al. 1995 Aging and endothelial function in normotensive subjects and patients with essential hypertension Circulation 91 1981 1987
47. L Ghiadoni Y Huang A Magagna, et al. 2001 Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension J Hypertens 19 547 551 10.1097/00004872-200103001-00005 (Pubitemid 32280946)
48. S Taddei A Virdis P Mattei, et al. 1996 Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients Circulation 94 1298 1303
49. GP Rossi S Taddei A Virdis, et al. 2003 The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients J Am Coll Cardiol 41 938 945
50. Cosentino F, Francia P, Musumeci B, De Siati L, Assunta Rao M, De Luca N, Balla C, De Sensi F, Volpe M (2006) Nitric oxide release is impaired in hypertensive individuals with familial history of stroke. Am J Hypertens 19:1213-1216
51. JA Panza PR Casino CM Kilcoyne AA Quyyumi 1993 Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension Circulation 87 1468 1474
52. S Taddei A Virdis L Ghiadoni, et al. 1998 Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension Circulation 97 2222 2229
53. Y Platina L Ghiadoni A Magagna, et al. 2007 Supplementation with vitamin C and E improves arterial stiffness and endothelial function in essential hypertensive patients Am J Hypertens 20 392 397 10.1016/j.amjhyper.2006.09.021 (Pubitemid 46442896)
54. S Taddei L Ghiadoni A Virdis, et al. 1999 Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients Circulation 100 1400 1405
55. S Taddei A Virdis L Ghiadoni, et al. 1999 Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension Circulation 100 1680 1683
56. S Taddei A Virdis L Ghiadoni, et al. 1997 Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension Hypertension 29 274 279
57. ME Widlansky DT Price N Gokce, et al. 2003 Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension Hypertension 42 310 315 10.1161/01.HYP.0000084603.93510.28 (Pubitemid 37093478)
58. NC Ward J Rivera J Hodgson, et al. 2004 Urinary 20- hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans Circulation 110 438 443 10.1161/01.CIR.0000136808.72912.D9 (Pubitemid 38993854)
59. MF Elias PA Wolf RB D'Agostino J Cobb LR White 1993 Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study Am J Epidemiol 138 353 364
60. I Skoog B Lernfelt S Landahl B Palmertz LA Andreasson L Nilsson G Persson A Odén A Svanborg 1996 15-year longitudinal study of blood pressure and dementia Lancet 347 1141 1145 10.1016/S0140-6736(96)90608-X (Pubitemid 126512042)
61. RJ Glynn LA Beckett LE Hebert MC Morris PA Scherr DA Evans 1999 Current and remote blood pressure and cognitive decline JAMA 281 438 445 10.1001/jama.281.5.438 (Pubitemid 29069442)
62. C Tzourio C Dufouil P Ducimetière A Alpérovitch 1999 Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of vascular aging Neurology 53 1948 1952
63. C Qiu B Winblad L Fratiglioni 2005 The age-dependent relation of blood pressure to cognitive function and dementia Lancet Neurol 4 487 499 10.1016/S1474-4422(05)70141-1 16033691 (Pubitemid 40982459)
64. RA Whitmer S Sidney J Selby SC Johnston K Yaffe 2005 Midlife cardiovascular risk factors and risk of dementia in late life Neurology 64 2 277 281
65. P Castri L Iacovelli A De Blasi F Giubilei A Moretti FT Capone F Nicoletti F Orzi 2007 Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease Eur J Neurosci 26 2469 2472 10.1111/j.1460-9568.2007.05869.x 17986027 (Pubitemid 350050441)
66. MF Folstein SE Folstein PR McHugh "Minimental state" 1975 A practical method for grading the cognitive state of patients for the clinician J Psychiat Res 12 189 198 10.1016/0022-3956(75)90026-6
67. T Erkinjuntti 2007 Vascular cognitive deterioration and stroke Cerebrovasc Dis 24 189 194 10.1159/000107395 17971655 (Pubitemid 350035866)
68. PROGRESS Management Committee 1996 Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS J Hypertens 14 41 46
69. JA Staessen R Fagard L Thijs, et al. 1997 Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators Lancet 350 757 764 10.1016/S0140-6736(97)05381-6 (Pubitemid 27387202)
70. L Hansson H Lithell I Skoog F Baro CM Bánki M Breteler PU Carbonin A Castaigne M Correia JP Degaute D Elmfeldt K Engedal C Farsang J Ferro V Hachinski A Hofman OF James E Krisin M Leeman PW de Leeuw D Leys A Lobo G Nordby B Olofsson A Zanchetti, et al. 1999 Study on COgnition and Prognosis in the Elderly (SCOPE) Blood Press 8 177 183 10.1080/080370599438310 (Pubitemid 29278940)
71. SHEP Cooperative Research Group 1991 Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 3255 3264 10.1001/jama.265.24.3255
72. M Di Bari M Pahor LV Franse RI Shorr JY Wan L Ferrucci GW Somes WB Applegate 2001 Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial Am J Epidemiol 153 72 78